ObjectiveGI is delivering provider partners and their patients participating in research a new, all-inclusive platform of clinical research data management.
“Our distributed technology further strengthens ObjectiveGI’s relationships with partner physicians by delivering more information and analytics within the framework of their existing patient care workflows,” says Colleen Hoke, CEO. “This ‘frictionless’ information-sharing approach supports mobile engagement for investigators, improving workflow integration and timely access to clinical research data.”
“This collaboration extends our data-driven solutions platform while maintaining our stringent security and data privacy requirements. The Clinical Research IO product infrastructure adheres to a stringent cloud-readiness process with security reviews, penetration testing and redundancy,” says Gerry Andrady, CTO. The new ObjectiveGI platform incorporates a clinical research–based eSource model that accepts multiple data formats and securely transforms those data sets into more comprehensive reporting and analytics. The result is usable information that can be readily reviewed and utilized within trial management.
ObjectiveGI is engaging next generation research systems to leverage resources and accelerate high-quality data collection, thus allowing for more efficient research execution throughout the patient care continuum.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
Vabysmo Shows Significant Vision Improvement for Diabetic Macular Edema in Underrepresented Patients
October 22nd 2024Phase IV ELEVATUM trial results show that one year of treatment with Vabysmo significantly improved vision in underrepresented racial and ethnic groups with diabetic macular edema, supporting the drug's efficacy and safety across diverse populations.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Clesrovimab Shows Significant Reduction in RSV Infections, Hospitalizations in Infants
October 18th 2024Merck's investigational monoclonal antibody, clesrovimab, shows significant efficacy in reducing respiratory syncytial virus-related infections and hospitalizations in infants, with a favorable safety profile.